AU2001272565A1 - Production in pichia pastoris yeast and system for purifying the recombinant allergen of olea europaea ole e 1 for utilization in the diagnosis and treatment of allergies - Google Patents

Production in pichia pastoris yeast and system for purifying the recombinant allergen of olea europaea ole e 1 for utilization in the diagnosis and treatment of allergies

Info

Publication number
AU2001272565A1
AU2001272565A1 AU2001272565A AU7256501A AU2001272565A1 AU 2001272565 A1 AU2001272565 A1 AU 2001272565A1 AU 2001272565 A AU2001272565 A AU 2001272565A AU 7256501 A AU7256501 A AU 7256501A AU 2001272565 A1 AU2001272565 A1 AU 2001272565A1
Authority
AU
Australia
Prior art keywords
allergies
purifying
diagnosis
utilization
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001272565A
Inventor
Eva Batanero Cremades
Rafael Monsalve Clemente
Rosalia Rodriguez Garcia
Maria Teresa Villalba Diaz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad Complutense de Madrid
Original Assignee
Universidad Complutense de Madrid
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad Complutense de Madrid filed Critical Universidad Complutense de Madrid
Publication of AU2001272565A1 publication Critical patent/AU2001272565A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2001272565A 2000-07-28 2001-07-19 Production in pichia pastoris yeast and system for purifying the recombinant allergen of olea europaea ole e 1 for utilization in the diagnosis and treatment of allergies Abandoned AU2001272565A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ESP200001919 2000-07-28
ES200001919A ES2209563B1 (en) 2000-07-28 2000-07-28 PRODUCTION IN THE LEVADURAPIPCHIA PASTORIS AND POMIFICATION SYSTEM OF THE OLEA EUROPEAN OLEA RECOMBINING ALLERGEN FOR USE IN DIAGNOSIS AND ALLERGY TREATMENT.
PCT/ES2001/000287 WO2002012503A1 (en) 2000-07-28 2001-07-19 Production in pichia pastoris yeast and system for purifying the recombinant allergen of olea europaea ole e 1 for utilization in the diagnosis and treatment of allergies

Publications (1)

Publication Number Publication Date
AU2001272565A1 true AU2001272565A1 (en) 2002-02-18

Family

ID=8494497

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001272565A Abandoned AU2001272565A1 (en) 2000-07-28 2001-07-19 Production in pichia pastoris yeast and system for purifying the recombinant allergen of olea europaea ole e 1 for utilization in the diagnosis and treatment of allergies

Country Status (3)

Country Link
AU (1) AU2001272565A1 (en)
ES (1) ES2209563B1 (en)
WO (1) WO2002012503A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003080837A1 (en) * 2002-03-22 2003-10-02 Universidad Complutense De Madrid Rectorado Production of recombinant che a 1 allergen from chenopodium album and system of isolating and purifying same
ES2199050B1 (en) * 2002-03-22 2005-03-01 Universidad Completense De Madrid "CHENOPODIUM ALBUM" RECEIVING ALLERGEN PRODUCTION CHE A 1 AND INSULATION AND PURIFICATION SYSTEM.
ES2293749B1 (en) * 2003-06-06 2009-03-16 Universidad Complutense De Madrid FRAE 1 ALLERGEN RECOMBINANT VARIANTE OF THE "FRAXINUS EXCELSIOR" FRENCH POLLEN, PICHIA PASTORIS YEAST PRODUCTION AND APPLICATIONS.
AT503690A1 (en) 2006-06-09 2007-12-15 Biomay Ag HYPOALLERGENIC MOLECULES
CN110567787A (en) * 2019-09-12 2019-12-13 浙江工商大学 Method for rapidly purifying IgG and IgE in serum

Also Published As

Publication number Publication date
WO2002012503A8 (en) 2002-09-19
ES2209563B1 (en) 2005-10-01
ES2209563A1 (en) 2004-06-16
WO2002012503A1 (en) 2002-02-14

Similar Documents

Publication Publication Date Title
DE60210409D1 (en) ARIPIPRAZOLE ACTIVE AGENT WITH LOW HYGROSCOPY AND METHOD FOR THE PRODUCTION THEREOF
PT1446122E (en) USE OF FLIBANSERIN IN THE TREATMENT OF DISORDERS OF SEXUAL DESIRE
EP1687733A4 (en) System and process for facilitating the provision of health care
EP1769791A3 (en) Treatment of Alzheimer's disease with cell cycle inhibitors
DE60217366D1 (en) SPHERICAL RIBBED SEALING BODY AND METHOD FOR PRODUCING THE SEALING BODY
NZ513984A (en) Pharmaceutical combinations for the treatment of stroke and traumatic brain injury
IL143699A0 (en) Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances
AU2002335794A1 (en) Allylamides useful in the treatment of alzheimer's disease
AU2003286285A1 (en) Use of fgf-18 in the diagnosis and treatment of memory disorders
FR2841470B1 (en) USE OF ISOFLAVONES FOR THE PREPARATION OF TOPICAL COMPOSITIONS USEFUL FOR PROMOTING SLIMMING AND ASSOCIATED COSMETIC TREATMENT METHOD
HUP0201997A2 (en) Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications
AU2001265186A1 (en) Use of epoxyeicosatrienoic acids in the treatment of cerebrovascular conditions
AU2001272565A1 (en) Production in pichia pastoris yeast and system for purifying the recombinant allergen of olea europaea ole e 1 for utilization in the diagnosis and treatment of allergies
AU2001274526A1 (en) Remedies for allergic diseases and process for producing the same
ATE299371T1 (en) ANTICONVULSIVES FOR THE TREATMENT OF AUTISM
AU2002352566A1 (en) Use of corrinoids in the treatment of skin diseases
AU2002364808A1 (en) Polynucleotide and protein involved in synaptogenesis, variants thereof, and their therapeutic and diagnostic uses
AU2003245415A1 (en) Vehicle for the medical treatment of persons in remote areas
PL1466604T3 (en) Isoquinoline derivatives, process for their preparation and use thereof in the treatment of melatoninergic system problems
HK1077521A1 (en) Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
HUP0202114A3 (en) Use of benzoic acid substituted benzopyrans in medicines useful for the treatment of atherosclerosis and the medicines
EP1375505A4 (en) Optically active alkenylphosphinic acid ester and process for producing the same
ID28738A (en) COMPOSITE SHEETS WHICH CAN BE SHOULD BE LIMITED FOR HEALTH OBJECTIVES OF THE BODY LIQUID ABSORER AND THE PROCESS OF MAKING IT
WO2001089548A3 (en) Pharmaceutical use of fibulin-1
FR2855056B1 (en) MEDICAMENT IN PARTICULAR FOR THE TREATMENT OF DREPANOCYTOSIS OR AIDS